Based on these properties, AAV9 was investigated in mice models of spinal muscular atrophy (SMA), a monogenic disease characterized by the degeneration of the spinal motor neurons, with positive results in motor neuron survival, reversal of the phenotype and increased survival (Dominguez et al
It reflects three completely different products being sold under the same name, in three different markets, with three different levels of medical oversight
Acknowledgements We acknowledge all the research staff for their contribution
The intra-day precision and accuracy we measured in triplicate on one day, while inter-day were evaluated on three consecutive days in a week
Tirzepatide is administered as a once-weekly subcutaneous injection, with doses ranging from 2.5 mg to 15 mg depending on the indication and patient tolerance
Mechanism of Action Comparison# CagriSema# CagriSema combines two distinct peptide mechanisms in a single injection